William Slattery
Director/Board Member at Transport Corporation of America, Inc.
Profile
William S.
Slattery is currently a Director at Transport Corporation of America, Inc., Chondrial Therapeutics, Inc., Vescor LLC, Bridge Medicines LLC, Appello Pharmaceuticals, Inc., Chondrial Therapeutics Holdings LLC, and an Advisor at The New York City Investment Fund Manager, Inc. He is also a Partner at Deerfield Management Co. LP (Private Equity).
In the past, he worked as a Director at SteadyMed Ltd.
and an Analyst at Amerindo Investment Advisors, Inc. He received his graduate degree from Rutgers State University of New Jersey and his undergraduate degree from State University of New York at Albany.
William Slattery active positions
Companies | Position | Start |
---|---|---|
Transport Corporation of America, Inc.
Transport Corporation of America, Inc. TruckingTransportation Transport Corporation of America, Inc. provides a wide range of truckload carriage and logistics services. It provides satellite-based communications with the fleet. The company was founded in 1984 and is headquartered in Eagan, MS. | Director/Board Member | 01/01/1998 |
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Director/Board Member | - |
Bridge Medicines LLC
Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Bridge Medicines LLC operates as a drug discovery company. It provides spanning therapeutic areas including infectious disease, oncology, neuropsychiatry, and rare diseases. The company was founded on November 1, 2016 and is headquartered in New York, NY. | Director/Board Member | - |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Director/Board Member | - |
Vescor LLC
Vescor LLC Pharmaceuticals: MajorHealth Technology Vescor LLC, engages in the discovery and development autophagy targeted therapeutics for cancer treatment. The firm develops small molecule inhibitors of a number of protein targets at critical nodes of the autophagy cascade, perform investigational new drug (IND) enabling studies, and move these into clinical development. The company was founded by Eileen White and Alec Kimmelman and is headquartered in New York, NY. | Director/Board Member | - |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Chondrial Therapeutics Holdings LLC engages in operation of a biotechnology firm. The company was founded in 2016 and is headquartered in Bala Cynwyd, PA. | Director/Board Member | - |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Private Equity Investor | 01/02/2000 |
The New York City Investment Fund Manager, Inc.
The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Consultant / Advisor | - |
Former positions of William Slattery
Companies | Position | End |
---|---|---|
STEADYMED LTD | Director/Board Member | - |
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of William Slattery
Rutgers State University of New Jersey | Graduate Degree |
State University of New York at Albany | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 10 |
---|---|
Transport Corporation of America, Inc.
Transport Corporation of America, Inc. TruckingTransportation Transport Corporation of America, Inc. provides a wide range of truckload carriage and logistics services. It provides satellite-based communications with the fleet. The company was founded in 1984 and is headquartered in Eagan, MS. | Transportation |
Amerindo Investment Advisors, Inc.
Amerindo Investment Advisors, Inc. Investment ManagersFinance Amerindo Investment Advisors Inc. is a San Francisco-based firm that manages institutional portfolios having a focus on Internet and Internet related issuers. The firm's separate account business consists of corporate ERISA plans, public pension plans, endowments, foundations, family trusts and high net worth individuals. Amerindo mutual funds are offered for the investor seeking a concentration in emerging technology with a focus on the Internet, health sciences and biotechnology. | Finance |
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Health Technology |
The New York City Investment Fund Manager, Inc.
The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Finance |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Finance |
Vescor LLC
Vescor LLC Pharmaceuticals: MajorHealth Technology Vescor LLC, engages in the discovery and development autophagy targeted therapeutics for cancer treatment. The firm develops small molecule inhibitors of a number of protein targets at critical nodes of the autophagy cascade, perform investigational new drug (IND) enabling studies, and move these into clinical development. The company was founded by Eileen White and Alec Kimmelman and is headquartered in New York, NY. | Health Technology |
Bridge Medicines LLC
Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Bridge Medicines LLC operates as a drug discovery company. It provides spanning therapeutic areas including infectious disease, oncology, neuropsychiatry, and rare diseases. The company was founded on November 1, 2016 and is headquartered in New York, NY. | Health Technology |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Health Technology |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Chondrial Therapeutics Holdings LLC engages in operation of a biotechnology firm. The company was founded in 2016 and is headquartered in Bala Cynwyd, PA. | Commercial Services |
- Stock Market
- Insiders
- William Slattery